Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
Tomasz M. Beer(Oregon Health & Science University), Andrew J. Armstrong(Duke Cancer Institute), Dana E. Rathkopf(Memorial Sloan Kettering Cancer Center), Yohann Loriot(Institut Gustave Roussy), Cora N. Sternberg(Carlo Forlanini Hospital), Celestia S. Higano(Seattle Cancer Care Alliance), Peter Iversen(Rigshospitalet), Christopher P. Evans(UC Davis Comprehensive Cancer Center), Choung‐Soo Kim(Asan Medical Center), Go Kimura(Nippon Medical School), Kurt Miller(Charité - Universitätsmedizin Berlin), Fred Saad(Université de Montréal), Anders Bjartell(Skåne University Hospital), Michael Borre(Aarhus University Hospital), Peter F.A. Mulders(Radboud University Nijmegen), Teuvo L.J. Tammela(Tampere University Hospital), Teresa Parli, Suha Sari, Steve van Os(Astellas Pharma (Netherlands)), Ad Theeuwes(Astellas Pharma (Netherlands)), Bertrand Tombal(Cliniques Universitaires Saint-Luc)
Cited by 413Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis